scholarly journals Host-Range Restriction of Vaccinia Virus E3L Deletion Mutant Can Be Overcome In Vitro, but Not In Vivo, by Expression of the Influenza Virus NS1 Protein

PLoS ONE ◽  
2011 ◽  
Vol 6 (12) ◽  
pp. e28677 ◽  
Author(s):  
Susana Guerra ◽  
Fernando Abaitua ◽  
Luis Martínez-Sobrido ◽  
Mariano Esteban ◽  
Adolfo García-Sastre ◽  
...  
2018 ◽  
Vol 92 (23) ◽  
Author(s):  
Gilad Sivan ◽  
Shira G. Glushakow-Smith ◽  
George C. Katsafanas ◽  
Jeffrey L. Americo ◽  
Bernard Moss

ABSTRACTReplication of vaccinia virus in human cells depends on the viral C7 or K1 protein. A previous human genome-wide short interfering RNA (siRNA) screen with a C7/K1 double deletion mutant revealed SAMD9 as a principal host range restriction factor along with additional candidates, including WDR6 and FTSJ1. To compare their abilities to restrict replication, the cellular genes were individually inactivated by CRISPR/Cas9 mutagenesis. The C7/K1 deletion mutant exhibited enhanced replication in each knockout (KO) cell line but reached wild-type levels only in SAMD9 KO cells. SAMD9 was not depleted in either WDR6 or FTSJ1 KO cells, suggesting less efficient alternative rescue mechanisms. Using the SAMD9 KO cells as controls, we verified a specific block in host and viral intermediate and late protein synthesis in HeLa cells and demonstrated that the inhibition could be triggered by events preceding viral DNA replication. Inhibition of cap-dependent and -independent protein synthesis occurred primarily at the translational level, as supported by DNA and mRNA transfection experiments. Concurrent with collapse of polyribosomes, viral mRNA was predominantly in 80S and lighter ribonucleoprotein fractions. We confirmed the accumulation of cytoplasmic granules in HeLa cells infected with the C7/K1 deletion mutant and further showed that viral mRNA was sequestered with SAMD9. RNA granules were still detected in G3BP KO U2OS cells, which remained nonpermissive for the C7/K1 deletion mutant. Inhibition of cap-dependent and internal ribosome entry site-mediated translation, sequestration of viral mRNA, and failure of PKR, RNase L, or G3BP KO cells to restore protein synthesis support an unusual mechanism of host restriction.IMPORTANCEA dynamic relationship exists between viruses and their hosts in which each ostensibly attempts to exploit the other’s vulnerabilities. A window is opened into the established condition, which evolved over millennia, if loss-of-function mutations occur in either the virus or host. Thus, the inability of viral host range mutants to replicate in specific cells can be overcome by identifying and inactivating the opposing cellular gene. Here, we investigated a C7/K1 host range mutant of vaccinia virus in which the cellular gene SAMD9 serves as the principal host restriction factor. Host restriction was triggered early in infection and manifested as a block in translation of viral mRNAs. Features of the block include inhibition of cap-dependent and internal ribosome entry site-mediated translation, sequestration of viral RNA, and inability to overcome the inhibition by inactivation of protein kinase R, ribonuclease L, or G3 binding proteins, suggesting a novel mechanism of host restriction.


Virology ◽  
1998 ◽  
Vol 251 (2) ◽  
pp. 334-342 ◽  
Author(s):  
Linda S. Wyatt ◽  
Miles W. Carroll ◽  
Claus-Peter Czerny ◽  
Michael Merchlinsky ◽  
Jerry R. Sisler ◽  
...  

1999 ◽  
Vol 27 (11) ◽  
pp. 2241-2247 ◽  
Author(s):  
A. M. Falcon ◽  
P. Fortes ◽  
R. M. Marion ◽  
A. Beloso ◽  
J. Ortin

Virology ◽  
1995 ◽  
Vol 212 (2) ◽  
pp. 422-428 ◽  
Author(s):  
Martin E. Nemeroff ◽  
Xiao-Yan Qian ◽  
Robert M. Krug
Keyword(s):  

2020 ◽  
Vol 95 (1) ◽  
Author(s):  
Yasuha Arai ◽  
Norihito Kawashita ◽  
Emad Mohamed Elgendy ◽  
Madiha Salah Ibrahim ◽  
Tomo Daidoji ◽  
...  

ABSTRACT Adaptive mutations and/or reassortments in avian influenza virus polymerase subunits PA, PB1, and PB2 are one of the major factors enabling the virus to overcome the species barrier to infect humans. The majority of human adaptation polymerase mutations have been identified in PB2; fewer adaptation mutations have been characterized in PA and PB1. Clade 2.2.1 avian influenza viruses (H5N1) are unique to Egypt and generally carry the human adaptation PB2-E627K substitution during their dissemination in nature. In this study, we identified other human adaptation polymerase mutations by analyzing phylogeny-associated PA mutations that H5N1 clade 2.2.1 viruses have accumulated during their evolution in the field. This analysis identified several PA mutations that produced increased replication by contemporary clade 2.2.1.2 viruses in vitro in human cells and in vivo in mice compared to ancestral clade 2.2.1 viruses. The PA mutations acted cooperatively to increase viral polymerase activity and replication in both avian and human cells, with the effect being more prominent in human cells at 33°C than at 37°C. These results indicated that PA mutations have a role in establishing contemporary clade 2.2.1.2 virus infections in poultry and in adaptation to infect mammals. Our study provided data on the mechanism for PA mutations to accumulate during avian influenza virus evolution and extend the viral host range. IMPORTANCE Clade 2.2.1 avian influenza viruses (H5N1) are unique to Egypt and have caused the highest number of human H5N1 influenza cases worldwide, presenting a serious global public health threat. These viruses may have the greatest evolutionary potential for adaptation from avian hosts to human hosts. Using a comprehensive phylogenetic approach, we identified several novel clade 2.2.1 virus polymerase mutations that increased viral replication in vitro in human cells and in vivo in mice. These mutations were in the polymerase PA subunit and acted cooperatively with the E627K mutation in the PB2 polymerase subunit to provide higher replication in contemporary clade 2.2.1.2 viruses than in ancestral clade 2.2.1 viruses. These data indicated that ongoing clade 2.2.1 dissemination in the field has driven PA mutations to modify viral replication to enable host range expansion, with a higher public health risk for humans.


Virology ◽  
1993 ◽  
Vol 196 (2) ◽  
pp. 682-693 ◽  
Author(s):  
Wan Chen ◽  
Robert Drillien ◽  
Danièle Spehner ◽  
R.Mark L. Buller

2010 ◽  
Vol 84 (19) ◽  
pp. 9907-9919 ◽  
Author(s):  
Christine Meisinger-Henschel ◽  
Michaela Späth ◽  
Susanne Lukassen ◽  
Michael Wolferstätter ◽  
Heike Kachelriess ◽  
...  

ABSTRACT Modified vaccinia virus Ankara (MVA) has a highly restricted host range in cell culture and is apathogenic in vivo. MVA was derived from the parental chorioallantois vaccinia virus Ankara (CVA) by more than 570 passages in chicken embryo fibroblast (CEF) cells. During CEF cell passaging, six major deletions comprising 24,668 nucleotides occurred in the CVA genome. We have cloned both the MVA and the parental CVA genome as bacterial artificial chromosomes (BACs) and have sequentially introduced the six major MVA deletions into the cloned CVA genome. Reconstituted mutant CVA viruses containing up to six major MVA deletions showed no detectable replication restriction in 12 of 14 mammalian cell lines tested; the exceptions were rabbit cell lines RK13 and SIRC. In mice, CVA mutants with up to three deletions showed slightly enhanced virulence, suggesting that gene deletion in replicating vaccinia virus (VACV) can result in gain of fitness in vivo. CVA mutants containing five or all six deletions were still pathogenic, with a moderate degree of attenuation. Deletion V was mainly responsible for the attenuated phenotype of these mutants. In conclusion, loss or truncation of all 31 open reading frames in the six major deletions is not sufficient to reproduce the specific MVA phenotype of strong attenuation and highly restricted host range. Mutations in viral genes outside or in association with the six major deletions appear to contribute significantly to this phenotype. Host range restriction and avirulence of MVA are most likely a cooperative effect of gene deletions and mutations involving the major deletions.


Virus Genes ◽  
1996 ◽  
Vol 12 (1) ◽  
pp. 89-94 ◽  
Author(s):  
Elizabeth Beattie ◽  
Elizabeth B. Kauffman ◽  
Hector Martinez ◽  
Marion E. Perkus ◽  
Bertram L. Jacobs ◽  
...  

2012 ◽  
Vol 86 (10) ◽  
pp. 5857-5866 ◽  
Author(s):  
J. M. Noronha ◽  
M. Liu ◽  
R. B. Squires ◽  
B. E. Pickett ◽  
B. G. Hale ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document